ENTA
ENANTA PHARMACEUTICALS INC · Healthcare · Market cap $329.4M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$183K
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Aug 10, 2026
Luly Jay R.
ENANTA PHARMACEUTICALS INC (ENTA) has 22 SEC Form 4 filings (36 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 10, 2026.
Inside the rolling window, 7 insiders at ENANTA PHARMACEUTICALS INC reported no open-market purchases and 9 open-market sales totaling $183K. The most recent open-market filing is a sale of 4,743 shares by President and CEO Luly Jay R., dated Dec 5, 2025, worth $67K.
- Industry:Biotechnology
- CEO:Jay R. Luly
- Employees:120
- HQ:Watertown, MA, US
- IPO:2013-03-21
| Source | |||||||
|---|---|---|---|---|---|---|---|
Luly Jay R.First filing | President and CEO | Sale | 4,743 | $67K | Dec 5 | -22.5% | SEC ↗ |
Or Yat SunFirst filing | Chief Scientific Officer | Sale | 2,390 | $34K | Dec 5 | -22.5% | SEC ↗ |
Rottinghaus Scott T.First filing | Chief Medical Officer | Sale | 798 | $11K | Dec 5 | -22.5% | SEC ↗ |
Kieffer Tara LynnFirst filing | Chief Product Strategy Officer | Sale | 2,106 | $30K | Dec 5 | -22.5% | SEC ↗ |
Luu BrendanFirst filing | Chief Business Officer | Sale | 1,394 | $20K | Dec 5 | -22.5% | SEC ↗ |
| See Remarks | Sale | 542 | $8K | Dec 5 | -22.5% | SEC ↗ | |
| See Remarks | Sale | 323 | $5K | Dec 5 | -22.5% | SEC ↗ | |
Trout Harry R. IIIFirst filing | See Remarks | Sale | 380 | $5K | Dec 3 | -20.6% | SEC ↗ |
Capps Kathleen S.First filing | See Remarks | Sale | 207 | $3K | Dec 3 | -20.6% | SEC ↗ |
Earnings: last 7 quarters
Congress trading ENTA 1 all-time
- DRep. Daniel GoldmanSale$1,001 - $15,0002023-07-12
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ENTA have?
ENANTA PHARMACEUTICALS INC (ENTA) has 22 SEC Form 4 filings (36 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Aug 10, 2026.
When was the most recent SEC Form 4 filing for ENTA?
The most recent Form 4 filing for ENTA on Tracefour is dated Aug 10, 2026.
What is the total insider buy and sell value at ENTA in the current window?
Inside the rolling window, insiders at ENTA bought $0 and sold $183K based on SEC Form 4 filings.
Can I get alerts for ENTA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ENANTA PHARMACEUTICALS INC (ENTA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ENANTA PHARMACEUTICALS INC is in the Healthcare sector.